Investment Summary |
|
|---|---|
| Date | 2006-09-11 |
| Target | Hi-G-Tek |
| Sector | Electronics |
| Investor(s) | L Capital Partners |
| Deal Type | Venture |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2004 |
| PE ASSETS | 165M USD |
| Size | Small |
| Type | Sector Focused |
L Capital Partners is a specialist private equity firm focused on investing in companies operating within the healthcare, technology, and energy/environmental sectors, looking to bring 'groundbreaking products to market'. Within healthcare, L Capital looks to invest in biopharmaceutical and medical device businesses. Within technology, the Firm's emphasis is on security/defense and IT businesses. And within the energy/environmental sector, the L Capital's focus is investing in opportunities that 'improve the quality of life'. L Capital was formed in 2004 and has offices in New York City and Tel Aviv, Israel.
| DEAL STATS | # |
|---|---|
| Overall | 6 of 16 |
| Sector: Electronics M&A | 1 of 1 |
| Type: Venture M&A Deals | 5 of 14 |
| State: Maryland M&A | 1 of 1 |
| Country: United States M&A | 6 of 15 |
| Year: 2006 M&A | 4 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2006-09-11 |
Aquarius Technologies
Port Washington, Wisconsin, United States Aquarius Technologies Inc. is a privately held company established to provide solutions for wastewater treatment in industrial and municipal applications. Today, Aquarius markets the patented no waste sludge MSABP™ and ELCAT™ toxic and non-biodegradable treatment technologies for these applications. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-02-13 |
Locus Pharmaceuticals
Blue Bell, Pennsylvania, United States A computational drug design company with a unique drug design and development platform. |
Buy | $30M |